1. Introduction {#s0005}
===============

The oleaginous yeast *Yarrowia lipolytica* has become the organism of choice for the production of oleochemicals ([@bib1], [@bib66]), biofuels ([@bib35], [@bib67]) and acetyl CoA-derived metabolites ([@bib71], [@bib34]). It has been extensively studied as a model organism for lipid accumulation ([@bib5]) and degradation ([@bib18]), dimorphism ([@bib50], [@bib44]) and protein secretory pathway ([@bib4]). *Y. lipolytica* is also recognized as a "generally regarded as safe" (GRAS) organism ([@bib24]) for the production of large quantities of citric acid ([@bib46], [@bib45]), α-ketoglutarate ([@bib70]) and succinic acid ([@bib14]) in the food industry. Coupled with its ability to natively utilize a wide range of substrates, such as glucose, fructose, glycerol and hydrocarbons, its low pH tolerance and strictly aerobic nature ([@bib1], [@bib34]), these properties make this yeast a very attractive candidate for industrial biotechnology applications. Notable examples of its industrial applications include the production of eicosapentaenoic acid (EPA)-rich products ([@bib68], [@bib60]), conjugated linoleic acid ([@bib69]), and cost-efficient production of lipid biofuels ([@bib7], [@bib49], [@bib67]).

Recent advances in understanding of *Y. lipolytica\'s* metabolic pathways, the sequencing of its genome ([@bib37]) and further expansion of its genetic toolbox have resulted in several successful endeavors to metabolically engineer this unconventional yeast to produce high-value compounds, e.g. limonene ([@bib11]) and γ-decalactone ([@bib23], [@bib10]). These achievements demonstrate the potential of *Y. lipolytica* as an industrial microbe to produce novel compounds and expand beyond its regular portfolio of fatty acids, fatty alcohols, biofuels, and protein production.

Although a number of gene over-expression and deletion tools have been established in *Y. lipolytica* ([@bib27]), the library of available tools is not as developed as that of other yeasts such as *Saccharomyces cerevisiae*. This is due in part to *Y. lipolytica* having a high frequency of non-homologous end-joining (NHEJ), while *S. cerevisiae* mainly utilizes the highly efficient homologous recombination repair machinery to repair DNA double-strand breaks ([@bib32], [@bib40]). Fickers *et al.* developed a gene disruption method by combining the sticky-end polymerase chain reaction (SEP) method and *Cre-lox* recombination system ([@bib19]). However, acceptable rates of recombination only occur when long homology regions (0.5--1 kb) are used, making this method less efficient in the absence of the *KU70* gene deletion ([@bib40]). Another hurdle in efficient genome-editing in *Y. lipolytica* lies in the fact that it has a less-defined non-coding RNA processing system. To solve this challenge, [@bib51] has used a hybrid tRNA promoter to express gRNA, allowing for efficient CRISPR-Cas9 targeting in *Yarrowia*. Alternatively, [@bib20]) demonstrated that the Type II RNA polymerase, in combination with the highly efficient hammerhead ribozyme and HDV ribozyme, could efficiently deliver gRNA and achieved multiplex genome-editing in *Y. lipolytica*.

In addition to genome-editing tools, advances have been made to develop a multi-copy, plasmid-based gene expression system, which is suitable for gene-expression fine-tuning due to the simplicity of plasmid construction and high transformation efficiency compared to the laborious and time-consuming genome manipulation process ([@bib38], [@bib40]). For example, Liu *et al*. engineered the low-copy CEN plasmid by fusing different promoters upstream of the centromeric region and improved both the copy number and gene expression level ([@bib38]).

In light of these advances, there is a pressing need for development of facile genetic tools that are tailored for modular and combinatorial pathway engineering in *Y. lipolytica* ([@bib61], [@bib63]). Indeed, metabolic engineering community has embraced the concepts of standardization and modularization to enable rapid construction of large pathway libraries covering a broad range of gene expression space ([@bib62], [@bib64], [@bib65]). This is often achieved by creating interoperable genetic parts with well-defined gene expression metrics. Here we report the development of a set of BioBrick vectors and its application in metabolic engineering. The engineered 12 YaliBricks vectors comprise four compatible restriction enzyme sites to enable modular pathway engineering and facile genetic operation. We established a sensitive and reliable luciferase reporter platform and characterized 12 endogenous promoters that have broad range of transcriptional dynamics. We demonstrate the versatility of the engineered YaliBrick vectors to construct gene clusters with unique transcriptional configurations: operon, pseudo-operon, monocistronic. In addition, we constructed a 12 kb, 5-gene biosynthetic pathway for the antibiotic pigment violacein using YaliBrick as a proof of concept for quick pathway assembly and screening. We incorporated our YaliBrick vector with genome-editing feature and successfully introduced indel mutation and frame-deletion deletion of the CAN1 (arginine permease) genomic loci of *Y. lipolytica*. We envision that the YaliBrick vectors will provide a powerful platform to facilitate modular manipulation of multigene pathways and the construction of complex genetic circuits in oleaginous yeast. These pYaliBrick vectors, along with several other relevant plasmids used in this study, will be deposited to Addgene soon for public access.

2. Materials and methods {#s0010}
========================

2.1. Strains and culture conditions {#s0015}
-----------------------------------

*Escherichia coli* NEB5α high efficiency competent cells were obtained from NEB for plasmid construction, preparation, propagation and storage. The *Y. lipolytica* wild type strain W29 was purchased from ATCC (ATCC20460). The auxotrophic Po1g (Leu−) was obtained from Yeastern Biotech Company (Taipei, Taiwan). All strains and plasmids are listed in [Supplementary Table S1](#s0090){ref-type="sec"}.

LB broth or agar plate with 100 µg/mL ampicillin was used to cultivate *E. coli* strains. Yeast rich medium (YPD) was prepared with 20 g/L Bacto peptone (Difco), 10 g/L yeast extract (Difco), and 20 g/L glucose (Sigma-Aldrich), and supplemented with 15 g/L Bacto agar (Difco) for solid plates. YNB medium was made with 1.7 g/L yeast nitrogen base (without amino acids and ammonium sulfate) (Difco), 5 g/L ammonium sulfate (Sigma-Aldrich), 0.69 g/L CSM-Leu (Sunrise Science Products, Inc.) or 0.67 g/L CSM-Leu-Ura (Sunrise Science Products, Inc.), and 20 g/L glucose. Selective YNB plates were made with YNB media supplemented with 15 g/L Bacto agar (Difco). For canavanine resistance selection, 0.70 g/L CSM-Arg (Sunrise Science Products, Inc.) and 15 g/L Bacto agar (Difco), supplemented with 50 μg/mL of canavanine, were used for YNB plates.

For promoter activity characterization, the media used for the shake flask fermentations contained 1.7 g/L yeast nitrogen base (without amino acids and ammonium sulfate), 5 g/L ammonium sulfate, 0.67 g/L CSM-Leu and 20 g/L glucose. Single *Y. lipolytica* colonies were picked from YNB selective plates and inoculated into YNB liquid media, which were grown at 30 °C overnight. Overnight cultures were inoculated into 50 mL of YNB media in 250 mL shake flasks with an initial cell density (OD600) of 0.01.

2.2. Plasmids construction {#s0020}
--------------------------

The 4 reporter genes hrGFP, mCherry, *E. coli* β-glucuronidase (EcUidA), and NanoLuc luciferase, and negative control *E. coli* biotin ligase (EcBirA) were PCR-amplified with the primers listed in [Supplementary Table S2](#s0090){ref-type="sec"} and inserted into a pYaliA1 vector backbone at the *SnaBI* and *KpnI* site via Gibson assembly ([@bib22]). The coding sequences of *vioA*, *vioB*, *vioC*, *vioD*, and *vioE* were PCR-amplified from *C. violaceum* genomic DNA and inserted into a pYaliA1 vector backbone at the *SnaBI* and *KpnI* site via Gibson Assembly. Each PCR amplicon was cloned downstream of the *Y. lipolytica* TEF promoter in the vector pYaliA1 backbone containing TEF promoter and intron sequence. Upon sequence verification, *vioA*, *vioB*, *vioC*, *vioD*, and *vioE* were assembled into a single pYaliA1 vector backbone by restriction enzyme digestion subcloning using the restriction sites *Avr*II, *Nhe*I, and *Cla*I (Fermentas, Thermo Fisher Scientific). The detailed assembly procedure is listed in [Fig. 4](#f0020){ref-type="fig"}B.

For construction of the operon configuration, the XbaI and SalI digested donor vector was gel purified and ligated to the *SpeI* and *SalI* digested destination vector. For pseudo-operon configuration, the *AvrII* and *SalI* digested donor vector was gel purified and ligated to the *SpeI* and *SalI* digested destination vector. For monocistronic configuration, the *Avr*II and SalI digested donor vector was gel purified and ligated to the *NheI* and *SalI* digested destination vector. Detailed cloning procedure is listed in [Fig. 3](#f0015){ref-type="fig"}A. This procedure was used to obtain all the six gene configurations N-o-B, N-p-B, N-m-B, B-o-N, B-p-N and B-m-N.

The 11 endogenous promoters were PCR-amplified using *Y. lipolytica* genomic DNA as the template. We typically amplify 1000 bp of gene sequence upstream of the structural DNA coding sequence. pYaliA1-NLuc was linearized with *Avr*II and *Xba*I and gel purified, then Gibson assembled with the 12 PCR amplicons, yielding a total of 12 pYaliBrick constructs including the original pYaliA1-NLuc plasmid.

Synthetic HHR-gRNA-Can1-tracrRNA-HDV ([Supplementary Table S2](#s0090){ref-type="sec"}) gene fragment was ordered from IDT and Gibson assembled into the *Xba*I and *Spe*I digested pYaliA1 vector. Humanized Cas9 attaching the nucleus localization signal was PCR amplified with p414-TEF1p-Cas9-CYC1t as template and Gibson assembled into the *SnaBI* and *KpnI* linearized pYaliA1 vector. All Gibson assembly cloned constructs were sequenced either through Genewiz or Quintara Biosciences. For assembling the gene construct containing both the Cas9 and CAN1 gRNA, AvII and NotI digested pYaliA1-gRNA-CAN1 was gel purified and ligated to the *NheI* and *NotI* digested pYaliA1-hCas9 to obtain the dual expression plasmid PYaliA1-hCas9-gRNA-ylCAN1.

All plasmids constructed were transformed into the *Y. lipolytica* host strain Po1g ΔLeu using the lithium acetate/single-strand carrier DNA/PEG method ([@bib12]).

2.3. hrGFP and mCherry fluorescence assay {#s0025}
-----------------------------------------

The strains bearing the fluorescent protein reporters GFP (excitation = 488 nm, emission = 509 nm) and mCherry (excitation = 587 nm, emission = 610 nm) were assayed with a Biotek H1 Synergy microtiter plate reader using whole cell cultures. Cell cultures were cultivated for 12 h in minimal YNB medium supplemented with 2% glucose at 30 °C and normalized to an OD~600~ of 1.

2.4. Lysate preparation for GUS and MUG assay {#s0030}
---------------------------------------------

Cells expressing EcUidA were picked from single colonies and grown in 3 mL minimal medium overnight at 30 °C. 50 mL shake flask cultures were inoculated with the overnight culture at an initial OD~600~ ≈ 0.01 and the cultures were harvested the following day at late-exponential phase. The cells harvested were normalized to an OD~600~ of 1 and pelleted via centrifugation. Crude protein extracts were obtained by a combination of incubation in cell lysis buffer supplemented with 1 mg/L Zymolyase and 1 min of mechanical lysing. Total protein concentration of lysates was quantified using Bradford reagent (Thermo Fisher Scientific). These lysates were then used for both the MUG assay and histochemical GUS staining assay as outlined in the methodology by [@bib27]). For each MUG assay reaction, 100 μL of lysate was added to 700 μL of GUS assay buffer (1 g/L 4-methylumbelliferyl β-D-glucuronide) and incubated at 37 °C for one hour. Aliquots of 100 μL were collected at 0, 30, 60 min time points and the quenched in 900 μL stop buffer (1 M Na~2~CO~3~). Fluorescence intensity measurements were taken with a Biotek H1 Synergy microtiter plate reader, at an excitation wavelength of 360 nm and emission wavelength of 455 nm. For the colorimetric GUS staining assay, 100 μL crude lysate was added to 500 μL staining buffer (2 mM 5-bromo-4-chloro-3-indolyl glucuronide) and incubated overnight at 37 °C.

2.5. Luciferase assay for promoter library characterization {#s0035}
-----------------------------------------------------------

All promoters were PCR-amplified from *Y. lipolytica* strain Po1g genomic DNA and cloned upstream of the luciferase reporter gene NLuc with the intronic sequence in the pYaliBrick vector bearing a leucine auxotrophic marker. Constructs were sequence-verified and transformed into the *Y. lipolytica* host strain Po1g ΔLeu. Single colonies were picked for culturing and subsequently harvested for protein extraction to perform the luciferase assay using the Nano-Glo Luciferase Assay System kit from Promega. Luminescence was measured with a Biotek H1 Synergy microplate reader.

2.6. Genome editing with CRISPR-Cas9 {#s0040}
------------------------------------

pYaliA1-hCas9 along with CAN1 sgRNA PCR product were transformed into *Y. lipolytica* Po1g ΔLeu strain to transiently disrupt the CAN1 gene. pYaliA1-hCas9-gRNA-ylCAN1 was transformed into *Y. lipolytica* Po1g ΔLeu for plasmid-based CAN1 disruption. All transformation cultures were plated onto CSM-Leu plates and incubated at 30 °C for two days. Colonies obtained were then spotted on CSM-Arg (yeast complete synthetic media without arginine) supplemented with 50 μg/mL canavanine and incubated at 30 °C incubator for three days to select for positive mutants. Canavanine-resistant colonies were inoculated into 2 mL YPD media and grown at 30 °C with shaking at 250 rpm overnight. *Y. lipolytica* genomic DNA was purified with the Promega Wizard genomic DNA purification kits. CAN1 gene was PCR amplified with the primer pairs Can1_F and Can1_R and analyzed by DNA gel electrophoresis. PCR products were cleaned-up by Zymo PCR concentrator clean-up kits and sent to Genewiz for DNA sequencing with Can1_seq as the sequencing primer.

3. Results and discussions {#s0045}
==========================

3.1. Developing a bioluminescence reporter system {#s0050}
-------------------------------------------------

Effective metabolic engineering of microorganisms relies on assembling and rewiring biosynthetic pathways to channel carbon flux towards producing compounds of interest. One of the most important aspects is to modulate gene expression and ideally achieve a balanced pathway expression with no metabolic bottlenecks. As such, it is crucial for metabolic engineers to be able to monitor gene expression levels via a stable, consistent, and reliable reporter system. In the case of genetic parts characterization, there are several reporter systems developed for this application; most assays utilize fluorescence or luminescence to detect and quantify gene expression. Fluorescence reporter activity can be measured either by the fluorescence intensity of the protein itself (as in the case of hrGFP and mCherry) or the specific enzymatic activity of the reporter using a fluorescent substrate (e.g. 4-methylumbelliferyl-β-D-galactopyranoside, MUG assay) ([@bib25]). On the other hand, bioluminescent assays utilize luciferase and, depending on the intrinsic nature of the enzyme, they require either luciferin and ATP or only coelenterazine as the substrate ([@bib25]).

To determine the best reporter system, four reporter genes hrGFP, mCherry, *E. coli* β-glucuronidase (EcUidA), and luciferase gene NanoLuc were constructed under the control of a constitutive TEF promoter carried by a self-replicating plasmid. We observed that the fluorescence readout was choppy and there was no consistent fluorescence expression pattern in both hrGFP or mCherry (Fig. 1A and B). Humanized hrGFP exhibited increased mean fluorescence intensity (MFI) with time across the four parallel biological replicates ([Fig. 1](#f0005){ref-type="fig"}A), albeit the sample-to-sample variation was large. Interestingly, mean fluorescence intensity (MFI) of mCherry was observed leveling off with time, possibly due to yeast cell autofluorescence (wavelength of mCherry emission is 610 nm). This indicates that either the expression of hrGFP and mCherry under the constitutive TEF promoter is very weak, or at least the yeast autofluorescence interferes with the detection. Humanized GFP (hrGFP) probably demonstrated better stability and functionality than mCherry under the tested condition; this is further corroborated by the fact that hrGFP reporter could be detected in *Y. lipolytica* using flow cytometry ([@bib8], [@bib29]), albeit with low sensitivity and detection limit.Fig. 1Evaluating the reliability and consistency of different reporter systems in *Y. lipolytica*. (A) hrGFP fluorescence protein as the reporter. MFI, mean fluorescence intensity. Four biological replicates were tested. (B) mCherry fluorescence protein as the reporter. Four biological replicates were tested. (C) β-glucuronidase (GUS) reporter with X-gluc (5-Bromo-4-chloro-3-indolyl-β-D-glucuronide) as substrate. Blue product could be quantified based on a spectrophotometric absorbance assay. (D) β-glucuronidase (GUS) reporter with MUG (4-methylumbelliferyl-beta-D-glucuronide) as substrate. Fluorescence product could be quantified with a fluorometric assay. Four biological replicates were tested. (E) Luciferase Nanoluc as the reporter. MLI, mean luminescence intensity. Three biological replicates were tested.Fig. 1

Next, we tested whether we could use the *E. coli* β-glucuronidase (encoded by *uidA*) as a reporter. β-glucuronidase (GUS) enzymatic activity in *Y. lipolytica* was measured using both fluorescent substrate (MUG, 4-methylumbelliferyl-β-D-galactopyranoside) and histochemical staining substrate (X-gluc, 5-bromo-4-chloro-3-indolyl-β-D-glucuronic acid). The colorimetric GUS staining assay took about 24 h to develop the color and did not demonstrate satisfactory detection of GUS activity ([Fig. 1](#f0005){ref-type="fig"}C). On the other hand, the fluorescent MUG assay was able to detect varying levels of enzymatic activity across all biological replicates of EcUidA-expressing strains with minimal background noise ([Fig. 1](#f0005){ref-type="fig"}D). Also, intron characterization was performed with the MUG assay by comparing enzymatic activity in stains with and without the intronic sequence fused downstream of the TEF promoter, revealing a 238-fold difference in fluorescence intensity in the strain with the intron-fused EcUidA over the intron-less EcUidA. This demonstrates the MUG assay\'s broad dynamic range spanning across about 2 orders of magnitude.

The main disadvantage of the MUG assay is the requirement to individually quench each sample in stop buffer before measuring fluorescence intensity, making it a rather inefficient and laborious process for multiplex assays. Another disadvantage is that the MUG assay is not amenable to time-course analysis of gene expression studies due to the fast kinetics of the MUG fluorophore emission.

To address these concerns, we turned to test the NanoLuc luciferase reporter by measuring the rate of luminescence emission from lysates of NLuc-expressing *Y. lipolytica* cells. Integration of the rate of luminescence emission exhibited a linear response curve with relatively small deviation from the mean luminescence intensity (mL) ([Fig. 1](#f0005){ref-type="fig"}E). Against the negative control BirA, the luminescence reporter in the NLuc-expressing strain yielded 104-fold higher signal than the baseline (BirA strain). The sensitivity of both the luciferase assay and MUG assay were similar when the strong, constitutive TEF promoter was used.

Bioluminescent luciferase assays have become the preferred reporter system for gene expression studies due to their high sensitivity and broad dynamic range ([@bib41]). The biggest advantage of using NanoLuc luciferase is the minimal background noise due to its independence of ATP. In contrast to the larger GUS reporter (EcUidA is encoded by 603 amino acid residues) and hrGFP reporter (240 amino acid residues), the NanoLuc luciferase only contains 171 amino acid residues, giving NanoLuc the advantage of quicker translation and folding and better expressibility. This makes NanoLuc luciferase an ideal reporter for monitoring rapid gene expression changes with minimal protein expression burden. Its smaller size is also beneficial in the construction of fusion proteins or split-proteins due to less probability of interfering with the functionality of the tagged protein.

3.2. Characterizing transcriptional activity of 12 promoters {#s0055}
------------------------------------------------------------

The highly complex transcriptional machinery in eukaryotes has resulted in many engineering efforts to identify and characterize core promoters and their proximal sequences. Given that endogenous gene expression elements are often used in pathway engineering in eukaryotes, and their transcriptional machinery is poorly understood and hard to predict, Hussain *et al.* systematically examined several common promoter components in yeast and engineered hybrid promoters by using in-tandem repeats of upstream activating sequences in conjunction with downstream truncated promoters to allow for a degree of predictability in gene expression ([@bib29]). For example, they have identified several promoters that are sensitive to oleic acid, and created an oleic acid-responsive hybrid acyl-CoA oxidase (POX2) promoter with modified core promoter and proximal sequences ([@bib29]). [@bib6] reported that *Y. lipolytica* extracellular protease (XPR2) promoter was regulated by a multitude of factors including pH, carbon, nitrogen and peptones. In addition, upstream activating sequence (UAS) regions have been suggested as the major player in mediating the response to those factors ([@bib57]). Dulermo *et al*. engineered variants of the TEF and LEU promoters by coupling different UAS1 elements in tandem and found that there is a positive correlation between the number of tandem UAS elements and expression levels ([@bib16]). In all, promoter engineering efforts in *Y. lipolytica* are highly restricted to a number of well-characterized promoters. Expanding the number of available endogenous promoters will provide alternative targets for further transcriptional engineering. It will also lead to the discovery of orthogonal promoters with minimal interdependence on native cell transcriptional machinery when there are considerations to decouple heterologous gene expression from the biomass precursor pathway. This allows for a more customizable approach in combinatorial gene expression optimization to selectively target different metabolic pathways.

We selected 11 endogenous promoters in addition to the well-characterized TEF promoter for genetic parts characterization ([Table 1](#t0005){ref-type="table"}). Given *Y. lipolytica\'s* ability to accumulate up to 50% of its dry cell weight as lipids ([@bib55]), the promoters chosen are primarily centering around the lipogenic pathways: the supply of acetyl-CoA and malonyl-CoA, the TCA metabolic pathway, glycolysis, the supply of NADPH from pentose phosphate pathway, and the lipid oxidation pathway ([Fig. 2](#f0010){ref-type="fig"}A). Unsurprisingly, the TEF promoter exhibited strongest expression levels, since the native TEF gene codes for the abundant translational elongation factor 1-α, which is essential for gene translation in all cells. Furthermore, in the case of *Y. lipolytica*, the TEF gene only exists as a single copy in the chromosome, implying that its promoter is very strong. The remaining 11 promoters derived from TCA cycle, glycolysis, pentose phosphate pathway or lipid oxidation pathway, demonstrated relative transcriptional activity ranging from 0.7% to 29.7% of TEF promoter activity ([Fig. 2](#f0010){ref-type="fig"}B). The top three candidates in this group are promoters found in glycolysis (pGAP promoter driving the expression of glyceraldehyde-3-phosphate dehydrogenase), glyoxylate cycle (pICL1 driving the expression of the isocitrate lyase), and a key precursor step of fatty acid biosynthesis (pACL2 driving the expression of the ATP: citrate lyase). The bottom two candidates in this promoter panel are involved in the supply of malonyl-CoA (pACC1driving the expression of acetyl-CoA carboxylase) and the supply of NADPH (pZWF1 driving the expression of the PP pathway glucose-6-phosphate dehydrogenase), which have been identified as the rate-limiting steps for efficient lipid biosynthesis ([@bib56], [@bib59]).Fig. 2Determining the transcriptional activity of 12 native promoters in *Y. lipolytica*. (A) Metabolic map of the 12 chosen structural genes that encode critical enzymes catalyze lipid biosynthesis in *Y. lipolytica*. (B) Characterizing the transcriptional activity of the 12 chosen promoters with luminescence as the readout. The details of the 12 chosen promoters can be found in [Table 1](#t0005){ref-type="table"}.Fig. 2Table 1List of promoters and their corresponding vector names.Table 1**Transcription unitAnnotationPromoter nameVector name**Translational elongation factor EF−1 alphaYALI0C09141gylTEF promoterpYaliA1Acyl-CoA: diacylglycerol acyltransferaseYALI0E32769gylDGA1 promoterpYaliB1Acetyl-CoA-carboxylase 1YALI0C11407gylACC promoterpYaliC1ATP citrate lyase 2YALI0D24431gylACL2 promoterpYaliD1Isocitrate dehydrogenase NAD+ subunit 2 mitochondrialYALI0D06303gylIDH2 promoterpYaliE1Fatty acid synthase subunit betaYALI0B15059gylFAS2 promoterpYaliF1Fatty acid synthase subunit alphaYALI0B19382gylFAS1 promoterpYaliG1Isocitrate lyase 1YALI0C16885gylICL1 promoterpYaliH1POX4 Fatty-acyl coenzyme A oxidaseYALI0E27654gylPOX4 promoterpYlaliJ1ZWF1 Glucose-6-phosphate dehydrogenaseYALI0E22649gYlZWF1 promoterpYaliK1Cytosolic NADP-specific isocitrate dehydrogenaseYALI0F04095gylIDP2 promoterpYaliL1Glyceraldehyde 3-phosphate dehydrogenaseYALI0C06369gylGAPHD promoterpYaliM1

Christen *et al*. performed metabolic flux analysis on several aerobic species of yeast including *Y. lipolytica* and found that the flux through the TCA cycle and pentose phosphate pathway equals the glycolytic flux ([@bib13]). In addition, Liu *et al*. demonstrated that the glyoxylate shunt is always active throughout different stages of growth, thus ensuring that the metabolite pools for the TCA cycle are replenished ([@bib39]). Taken together, the flux through the glyoxylate shunt and the reactions leading to acetyl-CoA formation would be high in correlation to measured metabolite pools. However, there is no clear correlation between high flux and promoter strength. Additional studies would be needed to determine optimal activation conditions for the promoters.

It is generally accepted that promoter architecture in eukaryotic organisms is extremely sophisticated in their regulatory mechanisms and the transcriptional responses are not as predictable compared to prokaryotic systems ([@bib29], [@bib47]). A notable example is the Snf1-mediated acetyl-CoA carboxylase regulation ([@bib52], [@bib54]). The 11 promoters identified in this study have not been fully characterized under different carbon, nitrogen and oxygen conditions. It is also noted that the sampling was performed at the late-exponential phase; it is known that gene activation and repression are correlated to the stages of growth. As such, the expression levels determined using the reporter assay may not reflect their optimal potential. Promoter activation and regulation can be mediated by different factors such as carbon source, nitrogen availability, pH, and metabolite levels ([@bib40], [@bib29]). Further investigation is needed to fully elucidate these new promoters to better understand each promoter element and determine its function in regulating gene expression and lipogenesis. In addition, characterizing promoters responsible for gene expression in central carbon metabolism and lipogenesis would better inform future metabolic engineering efforts in fine-tuning native pathways without the need for replacement of the native promoter, which avoids potential disruption of regulatory mechanisms.

3.3. Gene configuration engineering {#s0060}
-----------------------------------

Comparative genomic studies revealed that *Y. lipolytica* is phylogenetically distant from other hemiascomycetous yeasts. It is considered a non-conventional, intron-poor species; however, among other hemiascomycetes, it has the highest number of introns in its genome to date. Yarrowia\'s relatively high intron density of 0.17 indicates that alternative splicing (AS) may play a major role in increasing the variance and complexity of its transcriptome ([@bib42]). The outcome of AS of mRNA generally falls into two categories: mRNA that can be translated into functional proteins or nonsense-containing mRNA that may generate truncated, potentially non-functional proteins. For example, alternative splicing has led to generation of two unique MDH transcripts encoding malate dehydrogenases with different N-terminal signaling peptides; upon translation, the expressed malate dehydrogenase is either localized in the mitochondria, cytosol or peroxisome ([@bib31]). Eukaryotes have a quality control mechanism, nonsense-mediated mRNA decay (NMD), that targets mRNA with premature termination codons for degradation, thus preventing their translation. Mekouar *et al*. investigated several instances of AS in *Y. lipolytica* gene models and found that it exhibits all modes of alternative splicing, predominantly generated by intron retention ([@bib42]). However, the resulting transcripts usually incorporated an early termination codon and led to nonsense-containing mRNAs.

Regardless, this concept of transcriptional interference provides a potential strategy to regulate gene expression levels without the need for in-depth promoter engineering and understanding of the complicated regulatory mechanisms underlying each promoter. In our pYaliBrick vectors, four compatible restriction enzyme sites are strategically placed in between the gene regulatory elements to allow for easy genetic operation when performing DNA assembly: operon, pseudo-operon, and monocistronic gene configurations ([Fig. 3](#f0015){ref-type="fig"}A). By taking advantage of isocaudomers with compatible ends, we can reuse the restriction sites infinitely in subsequent cloning steps, enabling rapid assembly of gene fragments without the need to design unique primers to incorporate new sites. This method is particularly useful for assembling pathways with multiple similar homologous regions or repeated parts, which is technically challenging for homologous recombination-based methods such as Gibson assembly or yeast transformation-based gene assembly ([@bib61]).Fig. 3Intron alternative splicing allows the construction of three gene configurations in *Y. lipolytica*. (A) Modular cloning procedure to generate three gene configurations in *Y. lipolytica*. (B) A detailed layout of a two-gene pathway varying in gene configuration and positional order. (C) Gel digestion pattern of the six gene configurations: lane 1, B-o-N; lane 2, B-p-N, lane 3, B-m-N; lane 4, ladder; lane 5, N-o-B; lane 6, N-p-B and lane 7, N-m-B. (D) Yeast transformation assay to evaluate the efficiency of the Ura3 marker restoring Ura3 auxotrophic phenotype. Plate 1, Ura3 marker positive control; plate 2, U-o-M; plate 3, U-p-M; plate 4, U-m-M; plate 5, M-o-U; plate 6, M-p-U; plate 7, M-m-U. U is an abbreviation for Ura3 and M is an abbreviation for mCherry. (E) Positional effects of gene configuration on gene expression efficiency as evaluated by luminescence readout in the six genetic variations. RLU: relative luminescence unit. Error bars are the standard deviation calculated from triplicate readouts.Fig. 3

The three gene configuration mimics the prokaryotic gene expression system. An operon configuration encodes two structural gene sharing the same promoter and terminator, with each of the gene containing an intron derived from the TEF gene at their 5′ end. The intron is built upstream of the structural gene but downstream of the ATG exon to allow spliceosome processing of multiple intron sequences ([@bib9]) and potentially generate functional mRNA transcripts encoding different enzyme functionality ([Fig. 3](#f0015){ref-type="fig"}B). Similarly, a pseudo-operon configuration encodes two structural gene sharing the same terminator but driven by separate promoters. And a monocistronic configuration encodes two structural gene driven by separate promoters and terminators ([Fig. 3](#f0015){ref-type="fig"}B). Our standard cloning procedure allows us to streamline the genetic operation and rapidly create the three unique gene configurations ([Fig. 3](#f0015){ref-type="fig"}A). For a 2-gene pathway, six unique genetic organization could be easily obtained ([Fig. 3](#f0015){ref-type="fig"}B) and later screened by double digestion analysis ([Fig. 3](#f0015){ref-type="fig"}C). A ladder pattern of gel electrophoresis image indicates the three unique gene configurations, as demonstrated in [Fig. 3](#f0015){ref-type="fig"}C.

To test how these three gene configurations affect expression levels, we assembled six distinct genetic constructs varying in gene order and configuration. The two genes encode the yeast auxotrophic marker Ura3 and a fluorescence reporter ([Supplementary Fig. S4](#s0090){ref-type="sec"}). Upon transformation into the Ura3-deficient (Ura3^-^) strain, we evaluated which gene configuration could better complement the Ura3-deficient phenotype. Colony based screening on CSM-Ura media allowed us to compare the relative expression level of the Ura3 gene and inform us how genetic structural variation correlates with mRNA transcription ([Fig. 3](#f0015){ref-type="fig"}D). This complementation experiment demonstrates that six out of the seven constructs could functionally express the Ura3 gene, with the exception of plate No. 3 which corresponds to Ura3 and mCherry arranged in pseudo-operon form ([Fig. 3](#f0015){ref-type="fig"}D). To further validate this result, we then constructed six additional plasmids bearing two genes: BirA and NLuc. BirA is used as a control to investigate positional effects. All constructs displayed weaker expression of luminescence relative to the single NLuc control ([Fig. 3](#f0015){ref-type="fig"}E), which is not unusual as gene expression becomes weaker in tandem genetic constructs driven by similar promoters due to transcriptional inhibition ([@bib53]). Constructs harboring NLuc as the first gene exhibited strongest light emission in the monocistronic format (N-m-B, [Fig. 3](#f0015){ref-type="fig"}E) followed by operon (N-o-B, [Fig. 3](#f0015){ref-type="fig"}E). However, the pseudo-operon configuration (N-p-B, [Fig. 3](#f0015){ref-type="fig"}E) showed baseline signal, indicating the possibility of non-functional NLuc. The pseudo-operon configuration N-p-B contains an additional promoter within the transcript ([Fig. 3](#f0015){ref-type="fig"}B). Given that NLuc is functionally expressed when it is configured as an operon ([Fig. 3](#f0015){ref-type="fig"}D and E), we can infer that the non-functionality observed in the pseudo-operon configuration may be due to the lack of the transcriptional termination signal, thus preventing the functional maturation of the first messenger RNA which encodes the NLuc luciferase. Thus, the transcript generated cannot be translated into functional NLuc, although BirA is functionally expressed.

When NLuc is located downstream of BirA, the intron in front of NLuc moves further down along the genetic construct. The weak luminescence signal detected in the operon construct (B-o-N, [Fig. 3](#f0015){ref-type="fig"}E) indicates that the spliceosome prefers to splice the intron which is in close proximity to the exon. That is, splicing the intron on the first gene BirA may inhibit splicing of the intron on the second gene (NLuc). This alternative splicing inhibition provides a novel approach to adjust the transcripts ratio of two proteins. On the other hand, BirA-NLuc in both pseudo-operon (B-p-N) and monocistronic (B-m-N) configurations retained NLuc functionality due to the production of functional NLuc mRNA and thus functional proteins, as indicated by the relatively strong luminescence signal ([Fig. 3](#f0015){ref-type="fig"}E). In addition, positional effects within the monocistronic configuration exhibited a 4.4-fold decrease in NLuc gene expression when NLuc is placed downstream of BirA compared to the N-m-B construct where NLuc is placed upstream of BirA ([Fig. 3](#f0015){ref-type="fig"}E). Taking this into consideration, designing metabolic pathways in a tandem configuration will require stronger promoters to drive the transcription of the downstream genes due to this positional effect. These results establish a foundation to study how introns affect the processing of mRNA. It also provides an alternative approach to encode complex metabolic activity into a well-defined genetic configuration.

3.4. Functional expression of multigene pathway {#s0065}
-----------------------------------------------

Violacein is a pigmented, indolocarbazole compound with interesting bioactivities such as antibacterial, anticancer, antiviral, trypanocidal, and antioxidant properties ([@bib33], [@bib17]). These properties make violacein an attractive antibiotic target. The gene cluster *vioABCDE* isolated from *Chromobacterium violaceum* is responsible for converting the precursor tryptophan to violacein via a combination of enzymatic and non-enzymatic steps. VioA, VioC, and VioD are flavin-dependent oxygenases, with VioA catalyzing the first key step in converting [L]{.smallcaps}-tryptophan to 2-iminoindole pyruvate ([Fig. 4](#f0020){ref-type="fig"}A). VioB is a heme protein that yields the dimeric structure due to the C-C bond formation between the β-carbons in the benzylic rings of the two tryptophan molecules. The unstable intermediate formed by VioAB then goes through an indole shift catalyzed by VioE. At this point, the VioABE intermediate protodeoxyviolaceinic acid ([@bib26]) can directly be catalyzed either by VioD followed by VioC, or directly by VioC, to form violaceinic acid and deoxyviolaceinic acid ([Fig. 4](#f0020){ref-type="fig"}A), respectively ([@bib28]).Fig. 4Modular assembly of the 12 kb five-gene violacein biosynthetic pathway with pYaliBricks in *Y. lipolytica*. (A) Five biosynthetic steps lead to the synthesis of violacein from tryptophan. A detailed description of the biosynthetic reactions could be found in the main text. (B) In-parallel cloning procedure to assemble the five-gene pathway. (C) Plasmid map of the final five-gene construct. CEN1-1, yeast centromere containing the autonomous replication sequence; ORI1001, yeast replication origin; Leu2, leucine auxotrophic marker; TEF, promoter; XPR2, terminator; AmpR, ampicillin resistance maker. (D) Digestion pattern of the recombinant plasmid containing the five-gene violacein biosynthetic pathway. (E) Representative picture of violacein-producing *Y. lipolytica* grown on CSM-Leu plate.Fig. 4

Previous studies have taken advantage of its strong violet color to develop quick visual screening tools. The purple pigment has allowed for evaluating DNA assembly strategies and balancing expression for various biotechnological applications ([@bib36], [@bib43]). To test our design strategies in a quick and effective manner, we constructed the 12 kb five-gene pathway for violacein production in our standardized pYaliBrick vectors. Our engineered pYaliBricks support the modular and in-parallel assembly of multiple gene constructs via streamlined genetic manipulation ([Fig. 4](#f0020){ref-type="fig"}B). To construct the five-gene pathway along with the regulatory control elements (promoters, introns and terminators), we performed three rounds of cloning in one week and assembled the five-gene pathway in a monocistronic configuration as illustrated in [Fig. 4](#f0020){ref-type="fig"}C. Sequence verification was quickly confirmed by the unique fragmentation pattern via restriction digestion ([Fig. 4](#f0020){ref-type="fig"}D). Upon transformation into the Po1g *Y. lipolytica* host, colonies exhibited various color ranging from white to deep purple ([Supplementary Fig. S5](#s0090){ref-type="sec"}). The phenotypic variance seen indicates the possibility of genetic instability of our *Y. lipolytica* host in retaining all functional genes in the violacein biosynthetic pathway. A dark purple colony was subsequently chosen ([Fig. 4](#f0020){ref-type="fig"}E) and cultivated in CSM-Leu minimal media, HPLC quantification of the chosen strain yielded about 31.5 mg/L violacein. This is the first demonstration of the functional expression of the five-gene violacein pathway in oleaginous yeast, albeit further strain optimization is required to improve the cost-competitiveness.

The pYaliBrick assembly vectors provide a rapid method of assembling large pathways containing multiple reused parts (promoter, intron, terminator), which otherwise would not be attainable through Gibson assembly cloning. Given that the process involves no PCR amplification and only relies on subcloning using highly specific restriction enzymes, it is not necessary to sequence the construct for each assembly. The high fidelity and specificity of restriction enzyme ensures the accuracy of the pYaliBrick assembly platform. The simplicity and ease of manipulation to combine and configure multiple genes in one vector makes the pYaliBrick DNA assembly method highly predictable and efficient. In addition to the 12 promoters that are built into our pYaliBrick cloning system, the constructed vectors provide a unique approach to balancing gene expression. Collectively, we were able to construct a 12 kb natural product biosynthetic pathway containing *vioABCDE* and all necessary gene regulatory elements into the pYaliBrick vector and demonstrated violacein production in *Y. lipolytica*.

3.5. Accommodating genome-editing feature into pYaliBricks {#s0070}
----------------------------------------------------------

CRISPR-Cas9 mediated genome editing technique has revolutionized the field of metabolic engineering and synthetic biology ([@bib48]; [@bib58]). The RNA-guided DNA nuclease (Cas9) specifically targets the genomic loci that are complementary to the designed spacer (or guide) sequence adjacent to a PAM motif (protospacer adjacent motif). A crRNA (CRISPR RNA) containing the 20 bp designed protospacer sequence joins with the tracrRNA (trans-activating CRISPR RNA) to form an active scaffold and recruit Cas9 endonuclease to target the genome and induce a site-specific double-strand break ([@bib30], [@bib57]). The double-strand break can be repaired either through non-homologous end joining (NHEJ) or homology-directed repair (HDR). A synthetic guide RNA (sgRNA) can be designed to contain both the crRNA and the tracrRNA for the facile delivery of guide RNA. The processing of tracrRNA and crRNA largely relies on the type III RNA polymerase and the activity of the ribonuclease P to deliver non-coding RNA. The less-characterized non-coding RNA processing system poses a potential challenge to efficiently deliver functional gRNA in *Y. lipolytica* ([@bib15], [@bib2]).

To encode gRNA into pYaliBrick vectors, we adopted the highly efficient self-cleavage ribozyme strategy ([@bib3], [@bib21], [@bib20]) and modified the type II RNA promoter to drive the expression of the single guide RNA (sgRNA). We chose to edit the CAN1 (arginine permease) genomic locus, as this genetic marker allows us to easily evaluate the mutation efficiency based on canavanine resistance. The sgRNA along with the tracrRNA are flanked by the hammer-head ribozyme at the 5′ end and the HDV ribozyme at the 3′ end ([Fig. 5](#f0025){ref-type="fig"}A). Functional expression of the designed gene cassette leads to the generation of hybrid ribozyme and gRNA transcripts. The two ribozymes catalyze a selective hydrolysis reaction that cleaves the linking phosphodiester to give rise to a functional sgRNA transcript ([Fig. 5](#f0025){ref-type="fig"}B).Fig. 5CRISPR-Cas9 mediated genome-editing of CAN1 gene in *Y. lipolytica*. (A) Design of single guide RNA (sgRNA) with type II promoter (TEF) driving the expression of CAN1 single guide RNA. CAN1: gRNA that target the arginine permease; HHR: hammer-head ribozyme; tracrRNA: trans-activating CRISPR RNA. (B) Secondary structure of the transcribed sgRNA flanked by upstream hammer-head ribozyme and downstream HDV ribozyme. Red arrow indicates the self-cleavage site. (C) PCR product fragments of the mutant CAN1 analyzed by gel electrophoresis. (D) CAN1 mutation efficiency in both transient sgRNA delivery and plasmid-based sgRNA delivery. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 5

Selective screening of yeast colonies grown on CSM-Arg plate supplemented with canavanine allowed us to easily identify canavanine resistance. PCR amplification of the mutant CAN1 led to the production of distinct gene fragment sizes, with some of the colonies completely lacking the CAN1, while others possessed a truncated form of CAN1 ([Fig. 5](#f0025){ref-type="fig"}C). Transient expression of sgRNA in linear cassette form (the exact PCR product is shown in [Fig. 5](#f0025){ref-type="fig"}A) along with a NLS-tagged Cas9 results in about 92% of colonies that were resistant to canavanine. Plasmid-based delivery of sgRNA was also tested and revealed no significant difference in the mutation rate compared to the transient expression of sgRNA ([Fig. 5](#f0025){ref-type="fig"}D). PCR product of the mutant CAN1 was later sequenced to verify the exact mutation across the CAN1 genomic locus. Our sequencing results indicate plasmid-based gRNA delivery yields about 12.5% on-target indel mutation, compared to the 7.2% on-target indel mutation in the transient expression ([Fig. 5](#f0025){ref-type="fig"}D). We believe that the low on-target indel mutation arose from the NHEJ (non-homologous end joining) repair mechanism, which is dominant in *Y. lipolytica*. Interestingly, we also observed complete deletion and partial deletion of CAN1 in the mutants ([Fig. 5](#f0025){ref-type="fig"}C), indicating the complexity of the DSB repair mechanism in this yeast.

4. Conclusion {#s0075}
=============

The NanoLuc luciferase assay is a simple and efficient reporting system for gene expression analysis. It also has the potential of being integrated into an automated workflow to vastly improve its throughput, and with its rapid optical detection method, this assay makes an indispensable tool for characterizing genetic parts in large-scale studies. In the context of genetic toolbox development in model organisms, we have established a reliable reporter system and opened the doors for a biosensor-based, top-down approach to pathway engineering and genetic circuits evaluation in *Y. lipolytica*. Given the complexity of eukaryotic gene expression, this reporter system will facilitate the characterization of novel genetic elements, as well as the elucidation of unique regulatory mechanisms.

In addition, the 12 endogenous promoters characterized here have expanded our library of genetic parts for fine-tuning gene expression. Positional effects and gene configurations were also examined in the context of the prokaryotic operon, pseudo-operon, and monocistronic gene arrangements to elucidate how genetic structural variation could lead to distinct gene expression patterns. Using these three genetic configurations, we proposed a novel strategy to generate functional operon-type gene expression through intron alternative-splicing mechanism. We studied the positional effects and discovered the mutual transcriptional inhibition among the adjacent gene cassette. This invention facilitates the control and optimization of gene expression at the proper level while avoiding the need to modify the complex transcriptional machinery. The five-gene pathway for the pigmented compound violacein was rapidly assembled in *Y. lipolytica* using the self-replicating YaliBrick vectors. Applying the gene expression-tuning strategies outlined in this paper, a high-producing violacein-producing strain was quickly identified via visual screening, and titers were subsequently quantified with HPLC. Incorporating the highly efficient self-cleavage ribozyme allows us to generate functional single guide RNA (sgRNA) and introduce site-specific indel mutations and frame-shift mutations, paving the way for further genome-editing optimization in *Y. lipolytica*. Taken together, the tools and strategies developed in this work can streamline the genetic manipulation of *Y. lipolytica* and accelerate the construction of multiple gene pathways for diverse industrial applications. Our work provides an efficient and versatile toolkit to upgrade *Y. lipolytica* as a powerful workhorse for natural product and oleochemical production.

Appendix A. Supplementary material {#s0090}
==================================

Supplementary material

The authors would like to acknowledge the Department of Chemical, Biochemical and Environmental Engineering, College of Engineering and Information Technology, Office of the Vice President for Research at University of Maryland Baltimore County for funding support.

Conflict of interest {#s0080}
====================

None declared.

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.meteno.2017.09.001](http://doi:10.1016/j.meteno.2017.09.001){#ir0005}.
